Home / Market News / $ONCO

$ONCO news and market catalysts

The 3 most recent market catalysts affecting $ONCO, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 0 high impact 0 bullish 2 bearish Biotechnology
Nov 11, 2026 Corporate Catalyst Bearish Impact 65
Onco-Innovations Limited Announces Termination of Performance-Based Funding Arrangement with Sorbie
Onco-Innovations Limited announced the termination of a performance-based funding arrangement with Sorbie. This event is significant because it unwinds a prior financial commitment…
Oct 29, 2026 Corporate Catalyst Neutral Impact 65
Oncoinvent Appoints Dr. Zuzana Jiráková Trnková as Chief Medical Officer
Oncoinvent's appointment of Dr. Zuzana Jiráková Trnková as Chief Medical Officer is a significant development for the company. Her primary responsibility will be to lead the strate…
Sep 14, 2026 Corporate Catalyst Bearish Impact 75
Onconetix Announces Bridge Financing Facility Of Up To $5M To Realbotix With Initial $2.5M Advance; Facility Cancelled In Full Upon Closing Of Pending Acquisition
This headline signals an imminent acquisition, a significant corporate event. For Onconetix, it implies strategic expansion, potentially into new technologies or markets, which cou…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.